Terpenia specializes in the vertically integrated production of medicinal cannabis full-spectrum extracts and cannabis flowers.
Building on our knowledge and with our passion for innovation we are committed to pioneering advancements in the medicinal cannabis sector, delivering precise and professional solutions for therapeutic applications.
“One’s destination is never a place, but a new way of seeing things.”
Terpenia’s cultivation and production facility is located in Northern Greece, within the prefecture of Serres. The region falls within the warm temperate zone (subtropics), exhibiting a Mediterranean climate marked by humid-mild winters and dry-hot summers. This climate proves to be ideal for cultivating specific strains of the cannabis plant, enabling us to grow high-quality, purely ecological cannabis.
Through a state-of-the-art extraction process, we are able to minimize the loss of volatile and fragile compounds, thereby gaining a broader spectrum of pharmacologically valuable terpenes. Our end-products are designed to feature a complex and rich palette of oils and flavors. Additionally, our extraction process minimizes the risk of biological contamination, such as fungal spores or bacteria. With a very low water activity (aw) value, our products ensure no subsequent microbial growth, eliminating the need for post-processing treatments like irradiation.
Our planned operations adhere to all pertinent European laws and regulations governing the production of pharmaceutical and herbal medicinal products.
All of our cultivation, production, and distribution activities strictly adhere to EU regulations and good practice guidelines, ensuring compliance with industry standards.
Sustainability: Our Promise & Values
At the core of all our operations is our environmental code of conduct, which will guide our research and production efforts and aims to consistently integrate ecological, social, and knowledge management aspects into our activities.
Despite being significantly more labor-intensive, we prioritize traditional building and manual cultivation methods over industrial techniques. Our facility will be constructed with a careful selection of materials, including wood and glass, chosen for their minimal environmental impact. By the third year of operation, our aim is to power the facility entirely with renewables, such as solar and wind energy, contributing to our commitment to environmentally conscious practices.
Conservative use of resources
We will employ manual and individual watering techniques for our plants to minimize water consumption, avoiding the high usage associated with automated irrigation systems. Additionally, our plants will grow solely on available sunlight within our advanced glass greenhouse, eliminating the need for artificial lighting.
We will exclusively utilize organic fertilizers, and our extraction process will be carried out using strictly natural, non-toxic substances. We plan to closely monitor our production process to ensure that we do not emit any environmentally harmful substances.
We are committed to maintaining a strong dedication to carrying out all activities with consistent ethical standards. Our approach focuses on ensuring that every action we take embodies integrity, transparency, and social and environmental responsibility.
We aim to generate direct employment in facility administration and cultivation, along with additional seasonal positions.
We plan to invest approximately one million euros annually in salaries, social security, and healthcare.
We intend to allocate 5% of our profits to school projects, scholarships, and local charitable and environmental initiatives.
“The Path is made by walking. By walking you make a path.“
Greece approves laws allowing the export of cannabis flowers and extracts.
- Official company founding
- Cultivation permits for medical cannabis in Greece
- Negotiations with new investors and partners
We plan our farming and production enterprise in Greece and seek new partners for research & development.
- New Partners: Research agreement with the University Hospital Bonn
- Establishing our Production Site in Alistrati – Serres
- Full-fledged team recruit
The Greek Parliament introduces law 4523/2018, authorizing the cultivation and processing of medical cannabis.
- Clarification process of the legal framework for the cultivation of medical cannabis in Greece and the export for sales and research purposes within the EU
Meet Our Team
Our team consists of internationally acclaimed experts from the
fields of medicine, molecular biomedicine and botany.
Dr. rer. nat. Pavlos Kokordelis
CEO | Molecular Biomedicine
Dr. rer. nat. Filip Fuchs
Head of Production | Molecular Botany
Maria Teresa Romano, PhD
Scientific Board | Molecular Biology & Genetics
Prof. Dr. med. Jürgen K. Rockstroh
Scientific & Medical Board | Medicine
Aylar Tafazzoli, PhD
Scientific Board | Genetics
Dr. rer. nat. Wolfram Lobin
Scientific Board | Botany
Dr. phil. Maxim Egorov
Scientific Board | Psychology, People & Culture
Get In Touch
For further information about Terpenia, inquiries about our products and research methods, or for press and other collaboration requests, please get in touch with us either by using the form below or via email.
Terpenia Phytotherapeutics P.C.
Terpenia specializes in cultivating and producing standardized medical cannabis extracts and flowers for the Greek and other European markets.
Our primary emphasis is on the development
of finished pharmaceutical formulations.